Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Journal of Personalized Medicine|May 28, 2022
Vaccination Coverage against Tetanus, Diphtheria, Pertussis and Poliomyelitis and Validity of Self-Reported Vaccination Status in Patients with Multiple SclerosisSilvan Elias Langhorst, Niklas Frahm, Michael Hecker, et al.Frontiers in Neurology|January 8, 2024
Polypharmacy in patients with multiple sclerosis and the impact on levels of care and therapy unitsFinn Brüggemann, Stefan Gross, Marie Süße, et al.Scientific Reports|October 28, 2025
Cost patterns of long-term prescribed medications in patients with multiple sclerosis in GermanyMichael Hecker, Birgit Berger, Niklas Frahm, et al.Scientific Reports|September 7, 2022
Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemicFelicita Heidler, Julia Baldt, Niklas Frahm, et al.Vaccine|April 27, 2022
General vaccination willingness and current vaccination status in relation to clinical and psychological variables in patients with multiple sclerosisBarbara Streckenbach, Julia Baldt, Felicita Heidler, et al.Journal of Neurology|September 4, 2025
Age-related differences in switching highly effective disease-modifying therapy in patients with multiple sclerosisDavid Ellenberger, Niklas Frahm, Alexander Stahmann, et al.Journal of Clinical Medicine|June 13, 2025
Discrepancy Between Vaccination Willingness and Actual SARS-CoV-2 Vaccination Status in People with Multiple Sclerosis: A Longitudinal StudyFelicita Heidler, Michael Hecker, Niklas Frahm, et al.Therapeutic Advances in Neurological Disorders|October 14, 2021
Treatment patterns in pediatric patients with multiple sclerosis in Germany-a nationwide claim-based analysisNiklas Frahm, Melanie Peters, Jörg Bätzing, et al.Multiple Sclerosis and Related Disorders|October 8, 2021
Characteristics of secondary progressive multiple sclerosis: Disease activity and provision of care in Germany - A registry-based/multicentric cohort studyNiklas Frahm, David Ellenberger, Firas Fneish, et al.Therapeutic Advances in Chronic Disease|August 12, 2022
Associated factors of potential drug-drug interactions and drug-food interactions in patients with multiple sclerosisJane Louisa Debus, Paula Bachmann, Niklas Frahm, et al.Pageof 4